Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Lalo
S. Lalo
Medicine
Pathology
AL amyloidosis
Immunology
Bortezomib
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloidosis
2009
Clinical Lymphoma, Myeloma & Leukemia
C. Gasparetto
Jeffrey A. Zonder
R. M. Snyder
Howard R. Terebelo
D. Benson
Nalini Janakiraman
Markus Y. Mapara
Jeffrey Matous
Vaishali Sanchorawala
S. Lalo
D Monsma
J. Abrams
Show All
Source
Cite
Save
Citations (0)
An exploratory feasibility study examining the addition of arsenic trioxide (ATO) and ascorbic acid (AA) to bortezomib, thalidomide, and dexamethasone (VTD) in the treatment of relapsed and refractory multiple myeloma
2008
Journal of Clinical Oncology
J. N. Valent
R. M. Snyder
Asfar S. Azmi
Ramzi M. Mohammad
T. Weyer
K. O’Riley
S. Lalo
M. Rivero-Perry
Jeffrey A. Zonder
Show All
Source
Cite
Save
Citations (0)
1